Home
NICE Guidance
Published Guidance
Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck
Technology appraisal guidance [TA172]
Published date:
24 June 2009
Guidance
This guidance has been updated and replaced by
NICE technology appraisal guidance 473
.